Does Wegovy affect the pill — and what should you do about it?

Semaglutide slows gastric emptying, which could theoretically affect how quickly an oral pill is absorbed, NHS guidance currently does not flag a proven reduction in pill effectiveness with semaglutide specifically.
The MHRA does advise using contraception throughout treatment and observing a wash-out period before trying to conceive, this applies to GLP-1 medicines as a class.
Tirzepatide (Mounjaro) carries a different, more specific warning: women on oral contraceptives should use an additional non-oral method for the first four weeks of treatment and for four weeks after each dose increase.
The safest step is to raise contraception with your prescriber at consultation, an adjustment to your contraceptive method or timing is straightforward to make before you start.

Short answer: the evidence is reassuring, but there is a practical caveat worth knowing. Semaglutide slows gastric emptying, and for women taking an oral combined or progesterone-only contraceptive pill, that raises a reasonable question about whether absorption is affected. Current NHS guidance suggests no equivalent concern about pill effectiveness with semaglutide — unlike tirzepatide, where the MHRA advises adding a backup method during dose increases. That said, 'no equivalent concern' is not the same as 'no conversation needed'; anyone starting Wegovy (including the new oral semaglutide tablet) should discuss their contraception with a prescriber before they begin. These are prescription-only medicines that require a clinical assessment, a prescriber is best placed to weigh up your individual situation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually says about semaglutide and oral contraceptives

Does semaglutide slow absorption enough to matter for the pill?

Semaglutide works partly by slowing the rate at which food and liquid leave your stomach. That same mechanism is what leads many people to feel full quickly on Wegovy, but it also raises a pharmacokinetic question: if the stomach empties more slowly, could an oral medicine taken at the same time reach the bloodstream in smaller or later amounts?

For oral semaglutide tablets specifically, the SmPC contains a dedicated section on this, because the tablet itself depends on careful absorption conditions. The Wegovy tablet is taken first thing in the morning on an empty stomach with a small amount of plain water, and you wait at least 30 minutes before taking anything else, including other oral medicines. That timing matters. If you take your contraceptive pill at the same moment as the Wegovy tablet, you could interfere with how both are absorbed. Space them by at least that 30-minute window, or discuss moving one of them to a different time of day with your prescriber.

For the weekly injection form of Wegovy, the picture is more settled. NHS England's guidance on weight-management injections does not list a reduction in pill effectiveness as a known concern for semaglutide, in contrast to tirzepatide, where a specific interaction warning exists. That distinction is worth understanding clearly.

How does semaglutide's interaction compare to Mounjaro's contraception warning?

The contrast between the two medicines is one of the questions our prescribers field most often. Tirzepatide (Mounjaro) carries a clear MHRA-backed instruction: women using oral contraceptives should add a non-oral backup method (condoms, for example) during the first four weeks of treatment and for four weeks after every dose increase. The reasoning is that tirzepatide's effect on gastric emptying is pronounced enough during that initial period to potentially reduce pill absorption.

Semaglutide does not carry the same dose-escalation-specific instruction. NHS guidance, including NHS Inform Scotland's information on diabetes and weight-loss medicines, notes the contrast explicitly. However, the class-level advice still applies: use effective contraception while you are on any GLP-1 medicine, and plan carefully if pregnancy is a possibility during or after treatment.

This is worth reading about in detail on our dedicated page covering Wegovy and birth control pills, which goes further into the pharmacology for anyone who wants the fuller picture. For women on a progesterone-only pill specifically, there is also a separate consideration covered at our page on Wegovy and the progesterone-only pill.

What should you actually do before starting Wegovy?

A few practical steps cover most situations well. First, tell your prescriber which contraceptive pill you take, name and dose if you have it to hand. They will factor that into their assessment. Second, if you are starting on oral semaglutide tablets, pay close attention to timing: the tablet goes first, then a minimum of 30 minutes before other oral medicines. This is not an optional preference, it affects how well both medicines work.

Third, clarify the wash-out period if conception is on the horizon. The MHRA advises a period off treatment before trying to conceive; your prescriber will give you the specific figure based on current guidance and your circumstances. Fourth, if anything changes (a new contraceptive prescription, a dose change, a switch from the injection to the tablet) flag it. Each of those events is worth a brief clinical check.

These are not complicated adjustments. They are the kind of conversation a prescriber has every day, and getting them right at the start is far easier than unpicking problems later. If you have questions about how Wegovy interacts with the pill in your specific situation, our prescribers are available seven days a week. You can also explore what starting treatment with nume actually involves, no referral, no waiting list, and every consultation reviewed by a GPhC-registered Independent Prescriber the same day. For context on what treatment costs, our Wegovy pill cost page sets out what a transparent private prescription includes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions